Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   The 8th CAR-TCR Summit is returning to Boston as […]

Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for long-term scalable manufacturing looks to propel oligonucleotide development to patients at a much faster rate. The 2nd Oligonucleotides CMC & Analytical Development Summit returns this […]

The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss. However, in a space that has also had to battle with multiple clinical failures, there’s a genuine need for […]

The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster. Whether […]

The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications. This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and […]

The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all making strides with improving risk assessments, monitoring, and mitigating against AAV gene therapy immunogenicity. Registering for 2023 will grant you access to keynote plenaries from […]

With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this year’s Event Guide below! 7th Complement-Based Drug Development Summit September 11-13, 2023 View Agenda Reuniting experts across Nephrology, Neurology, Ophthalmology, and Haematology, join the leading companies showcasing the […]

Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and […]

Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to give industry the opportunity to unite towards a shared goal and share strategic […]

Wearable Injectors and Connected Devices USA Conference: September, 13 – 14 2023 Boston, USA Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL Advancing digital health and on-body drug delivery devices for enhanced patient experience Following the success of the Wearable Injectors and Connected Devices Europe conference, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma, […]

FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to Phase 3 trials to get the next disease-modifying drug to the patients in need. The 7th IPF Summit (September 19-21 | Boston) returns at this crucial stage for […]

Returning to Boston as the world’s only industry-leading meeting focused on mRNA process development and manufacturing, join 200+ VPs, Directors and Heads of Process Development, MSAT, Technical Operations, CMC and more from large pharma, innovative biotechs, and academia. Download the program here: https://ter.li/5o4hdl This must-attend meeting will provide you with technical insight and know-how from the […]